AP

Ana Bastiani Posner

Ana Bastiani-Posner


Executive Vice President & Chief Financial Officer



Professional Overview
Ana Bastiani-Posner is an accomplished finance executive with over 20 years of experience in the pharmaceutical and biotechnology industries. As the Executive Vice President and Chief Financial Officer at Kyowa Kirin, Inc. - U.S., she is responsible for leading the company's financial strategy, overseeing financial operations, and driving strategic decision-making to support the organization's growth and success.

Experience Summary

Current Role
In her current role at Kyowa Kirin, Inc. - U.S., Ana is responsible for managing the company's financial resources, ensuring financial reporting compliance, and implementing cost-effective strategies to maximize profitability. She works closely with the executive team to develop and execute financial plans that align with the organization's long-term objectives.

Career Progression
Prior to joining Kyowa Kirin, Ana held senior finance roles at respected organizations in the pharmaceutical and life sciences sectors. As the Senior Vice President and Chief Financial Officer at the New York Genome Center, she played a pivotal role in the center's financial planning and analysis, helping to drive its growth and strategic initiatives. Earlier in her career, she held various finance leadership positions at Allergan, Novartis Pharmaceuticals, and Schering-Plough, where she honed her expertise in financial management, business planning, and global operations.

Academic Background
Ana holds a Master's degree in Business Administration from the University of São Paulo, Brazil, and a Bachelor's degree in Accounting from the Universidade Federal de Minas Gerais, Brazil.

Areas of Expertise
  • Financial management and strategic planning

  • Cost optimization and resource allocation

  • Financial reporting and compliance

  • Mergers, acquisitions, and integration

  • Operational efficiency and process improvement

  • Risk management and mitigation


Professional Impact
Throughout her career, Ana has demonstrated a track record of driving financial excellence and supporting the growth of leading pharmaceutical and biotechnology companies. Her strategic leadership and collaborative approach have been instrumental in improving financial performance, optimizing business operations, and positioning organizations for long-term success.

Conclusion
With her extensive experience, deep industry knowledge, and proven ability to navigate complex financial and operational challenges, Ana Bastiani-Posner is a valuable asset to Kyowa Kirin, Inc. - U.S. As the Executive Vice President and Chief Financial Officer, she is well-equipped to guide the company's financial strategy, enhance profitability, and contribute to its continued growth and success in the dynamic pharmaceutical industry.